Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-ML-10 PET for Brain Metastases Response
NCT00805636Phase 2Unknown
- Sponsor
- Aposense Ltd.
- Start
- Nov 2008
- Primary completion
- Oct 2010
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]ML10 in brain metastases, sponsored by Aposense Ltd.. Status: unknown.
02
Drugs
[18F]ML10
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00805636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805636.